Abstract
Monoamine-oxidase catalyses the oxidative deamination of various primary amines such as norepinephrine, serotonin, dopamine and others. Such an enzyme exists under two well known isotypes, A and B. In the brain monoamine-oxidase activity increases with ageing. The present paper reports data regarding the evaluation on the activity of monoamine-oxidase A and B in murine neuroblastoma cells carried out by a radioassay upon acute or chronic treatment of cells by aluminium or tacrine. Our data show that aluminium has a pronounced activatory effect on both enzymatic isoforms either in acute or long-term adaptation treatment. Conversely, tacrine produces an inhibitory effect of both monoamine oxidase isotypes after an acute treatment, while an inhibitory effect on the isoform A and an activation of the isoform B in long-term adaptation was observed. Such effects are discussed in terms of aluminium neurotoxicity and therapeutic implications for tacrine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
